← Leaderboards
Monika A Davare
Oregon Health & Science University
$1,467,915
Attributed
$1,467,915
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $305K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,467,915 · 1
By mechanism
R01$1,467,915 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Sudarshan Rajan Iyer$241,607
- Peter Nicholas Robinson$10,536,686
- Haijiao Zhang$1,696,427
- Zheng David Qian$4,913,102
- Anupriya Agarwal$8,829,719
Others in their field
Other Emerging Leaders on “Biochemical”
- John Damon Chodera · Sloan-Kettering Inst Can Research$47,159,667
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Robert J Woods · Virginia Polytechnic Institute And State University$12,760,318
- Bryan Roth · Univ Of North Carolina Chapel Hill$12,367,722
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Neil King · University Of Washington$9,764,305
Research focus
BiochemicalBiologicalBiological MarkersBiological ModelsCancer GenomeCancer GenomicsCancer TypeCatalysisCdna ExpressionCell ModelCell TransformationChimeric ProteinsChromosomal RearrangementClinical TranslationCombinatorialCrispr/Cas TechnologyCrizotinibDown-RegulationDrug SensitivityEligibility DeterminationEngineeringExhibitsExperimental StudyFuture
Grant awards (5)
Functional impact, mechanistic role, and targetability of ROS1 aberrations in cancer$281,116
R01 · FY2024 · CA · contact PI
Functional impact, mechanistic role, and targetability of ROS1 aberrations in cancer$289,993
R01 · FY2023 · CA · contact PI
Functional impact, mechanistic role, and targetability of ROS1 aberrations in cancer$304,984
R01 · FY2022 · CA · contact PI
Functional impact, mechanistic role, and targetability of ROS1 aberrations in cancer$295,911
R01 · FY2021 · CA · contact PI
Functional impact, mechanistic role, and targetability of ROS1 aberrations in cancer$295,911
R01 · FY2020 · CA · contact PI